Table 2. Deaths and thromboembolic events.

During the study period, a total of 17 deaths (Section A) and 69 thromboembolic events (Section B) were sustained by 78 patients. Events are segregated into the segments of the study during which they occurred (from enrollment to Day 5; from Day 5 to Day 30; and from Day 30 to Day 90).

A. Deaths
Timing	Cause of Death
Before Day 30 (n=6)	Cardiac arrest (n=1) Cardiac failure (n=1) Complications of diabetes (n=1) Renal failure (n=1) Trauma-induced subarachnoid hemorrhage (n=1) Unknown (n=1)
Days 30–90 (n=11)	Cardiac arrest (n=1) Cardiac failure (n=1) Myocardial infarction (n=1) Malignancy, respiratory failure (n=1) Sepsis (n=2) Ruptured thoracic aortic aneurysm (n=1) Unknown (n=4)
B. Thromboembolic Events
Before Day 5 (n=3)	Peripheral arterial thrombosis and VTE (n=1) Thrombotic stroke/TIA (n=1) VTE (n=1)
Days 5–30 (n=46)	HIT/HITT (n=5) VTE (n=21) Acute coronary syndrome/MI/graft thrombosis (n=5) Thrombotic stroke/TIA (n=10) Left atrial appendage thrombosis (n=1) Peripheral arterial thromboembolism (n=2) Unspecified thrombosis/IVC filter placement (n=2)
Days 30–90 (n=20)	HITT (n=1) VTE (n=8) Acute coronary syndrome/MI/graft thrombosis (n=7) Thrombotic stroke/TIA (n=3) Peripheral arterial thromboembolism (n=1)

Abbreviations used include: VTE, venous thromboembolism; TIA, transient ischemic attack; HIT, heparin induced thrombocytopenia; HITT, heparin induced thrombocytopenia and thrombosis; IVC, inferior vena cava.